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the host immune system, as well as in promoting various 
physiological processes in the human gut, such as the estab-
lishment of mucosal integrity and the mucus gel layer [5, 6].
Furthermore, later in life the abundance and prevalence 
of particular members of the human gut microbiota con-
tinue to play a variety of roles in the maintenance of human 
health, for example, by (i) assisting in the breakdown of food 
components and liberation of nutrients that would otherwise 
be inaccessible to the host, (ii) promoting the differentia-
tion of particular host tissues, (iii) reducing the risk of gut 
colonization by pathogens, and (iv), as already mentioned 
above, maturation and modulation of the immune system. 
As underlined by several studies, the development of the 
complex microbial assemblage within a specific ecologi-
cal niche reaches a so-called climax status represented by 
the establishment of a balanced equilibrium of its microbial 
components [7]. Numerous factors are known to cause shifts 
in the composition of the microbiota, thereby disrupting this 
microbial homeostasis and causing a state of dysbiosis. Dys-
biosis is typically associated with having a negative impact 
on host health with long-term consequences, being asso-
ciated with various disorders or diseases, such as obesity, 
diabetes, inflammatory bowel disease (IBD), and metabolic 
syndrome.
However, despite the wealth of publications that support 
the key roles played by gut microbiota in host health main-
tenance and promotion, there are still substantial knowledge 
gaps related to the associated mechanisms of action. Another 
intriguing finding of the metagenomic era is represented by 
the identification of numerous, but as yet uncharacterized 
microbial taxa that have overwhelmed bacterial taxonomy. 
Such newly discovered taxa represent a challenging frontier 
for microbiology research that focuses on the development 
of methodologies for the isolation and cultivation of these 
novel microbes.
Abstract The gut microbiota represents a highly complex 
assembly of microbes, which interact with each other and 
with their host. These interactions have various implications 
in terms of health and disease, and this multi-author review 
issue will address a number of selected aspects pertaining 
to gut microbiota research.
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Human beings are colonized by complex microbial com-
munities that influence and govern various biological pro-
cesses during their entire lifespan. Within the human body, 
microbes reach their highest density in the intestinal tract, 
where they form a complex microbial community known as 
the gut microbiota [1]. This gut microbiota develops during 
infancy of the host to reach its mature form following wean-
ing [2–4]. The human gut microbiota in the early stages of 
life plays a pivotal role in the maturation and modulation of 
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This multi-author review will cover a variety of topics, 
including the development of the gut microbiota following 
birth and the impact of antibiotics either prenatally or post-
natally on these early microbial communities (see Nogacka 
et al.). In the context of early life microbiota, one particular 
group of gut commensals, the bifidobacteria, represents a 
dominant and prevalent microbial group. The contribution 
by Turroni et al. provides an overview of the ecological and 
biological role of bifidobacteria in the infant gut.
The multi-author review is counter-balanced by three arti-
cles focusing on gut microbiota composition in aging organ-
isms, from flies to humans. The contribution by Clark and 
Walker presents a detailed overview of the role of gut micro-
biota in age-associated health decline as determined by the 
use of invertebrate models. In addition, in this context, the 
contribution by O’Toole and Jefferey provides insights into 
the composition of the gut microbiota of elderly, with par-
ticular emphasis on the role of microbial effector metabolites 
in host-signaling and impact on host health status. The con-
tribution by Santoro et al. documents our current knowledge 
on gut microbiota composition at the extreme end of human 
life, namely in centenarians, providing relevant findings on 
the role of gut microbiota in neurodegenerative diseases, 
such as Parkinson’s and Alzheimer’s diseases.
Finally, comparative analysis of gut commensals found 
in two different mammalian species, humans and mice, 
revealed that they had a relatively small number of microor-
ganisms in common (Hugenholtz and de Vos), and reminds 
us that extreme caution should be taken when findings from 
murine analyses are being extrapolated to humans.
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